TMDX — TransMedics Group, Inc.
$70.63-0.16%
Last close: · regular session
Last 60 sessions
TMDX closed at $70.63 (-0.16%) on Oct 26, 2026. Float: 33.0M shares. Latest SEC filing: 8-K on Aug 4, 2026.
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for TMDX in the TickerWise workspace.
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
Company profile
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
- Exchange: NASDAQ
- Employees: 728
- Website: https://www.transmedics.com
Latest SEC filings for TMDX
Latest TMDX news
- TransMedics selects Gogo Galileo HDX for nationwide organ transport fleet Read article
Related companies
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.